Gene therapy, stress haematopoiesis and the risk of malignancy [ 2010 - 2013 ]

Also known as: The risk of malignancy in bone marrow-targeted gene therapy

Research Grant

[Cite as]

Researchers: Prof Ian Alexander (Principal investigator) ,  Prof Stephen Alexander Dr Samantha Ginn A/Pr Matthew Mccormack Prof Adrian Thrasher

Brief description The immense potential of gene therapy has been confirmed by the successful treatment of immune deficiencies disorders. A key issue that has emerged however is the need to avoid potentially cancer-causing genetic damage to cells undergoing repair. Some of this risk can be linked to the gene repair technology used, but we have identified and propose to investigate another potentially important mechanism involving the unusually high levels of replication imposed on cells during disease correction.

Funding Amount $AUD 617,354.91

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]